Rambus Operating Cash Flow decreased by 16.6% to $83.21M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.5%, from $77.41M to $83.21M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 14.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.59M | $46.00M | $72.17M | $42.61M | $56.50M | $79.99M | $51.29M | $38.91M | $50.44M | $51.59M | $54.85M | $39.12M | $70.42M | $62.07M | $58.98M | $77.41M | $94.36M | $88.43M | $99.82M | $83.21M |
| QoQ Change | — | -10.8% | +56.9% | -41.0% | +32.6% | +41.6% | -35.9% | -24.1% | +29.7% | +2.3% | +6.3% | -28.7% | +80.0% | -11.9% | -5.0% | +31.2% | +21.9% | -6.3% | +12.9% | -16.6% |
| YoY Change | — | — | — | — | +9.5% | +73.9% | -28.9% | -8.7% | -10.7% | -35.5% | +6.9% | +0.5% | +39.6% | +20.3% | +7.5% | +97.9% | +34.0% | +42.5% | +69.2% | +7.5% |